Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Wendy Armstrong

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
63
2024
2729
6.090
 Why?
Epidemics
6
2024
82
2.160
 Why?
Communicable Diseases
8
2023
152
1.960
 Why?
Anti-Retroviral Agents
5
2019
231
1.750
 Why?
Anti-HIV Agents
13
2024
757
1.630
 Why?
Viral Load
13
2023
449
1.200
 Why?
Infectious Disease Medicine
2
2017
12
1.120
 Why?
Continuity of Patient Care
5
2022
276
1.030
 Why?
Internal Medicine
3
2016
245
0.950
 Why?
Social Stigma
2
2024
116
0.940
 Why?
AIDS-Related Opportunistic Infections
5
2019
123
0.940
 Why?
HIV
13
2023
227
0.930
 Why?
Drug Monitoring
2
2016
214
0.800
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
18
0.790
 Why?
Internship and Residency
6
2021
1049
0.780
 Why?
Pre-Exposure Prophylaxis
3
2024
205
0.730
 Why?
Adenine
2
2020
257
0.680
 Why?
Antiretroviral Therapy, Highly Active
6
2019
267
0.670
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
17
0.660
 Why?
Diagnostic Tests, Routine
2
2021
103
0.640
 Why?
Acquired Immunodeficiency Syndrome
7
2022
228
0.630
 Why?
Humans
91
2024
129527
0.620
 Why?
Consumer Advocacy
1
2018
12
0.600
 Why?
Health Services Accessibility
4
2024
897
0.590
 Why?
Career Choice
3
2018
206
0.590
 Why?
Lost to Follow-Up
2
2017
21
0.580
 Why?
United States
25
2024
13865
0.580
 Why?
Health Policy
3
2023
350
0.550
 Why?
Delivery of Health Care
4
2021
896
0.540
 Why?
Substance-Related Disorders
6
2021
1022
0.520
 Why?
CD4 Lymphocyte Count
6
2020
267
0.520
 Why?
Georgia
10
2024
80
0.500
 Why?
Medication Adherence
2
2017
560
0.480
 Why?
Antimicrobial Stewardship
3
2023
107
0.480
 Why?
Disease Management
1
2019
591
0.470
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
12
0.460
 Why?
Biomedical Research
2
2018
639
0.450
 Why?
Urban Population
1
2017
442
0.440
 Why?
Bone Diseases
1
2014
57
0.430
 Why?
Financing, Government
1
2014
43
0.430
 Why?
HIV-1
5
2016
839
0.430
 Why?
Patient Acceptance of Health Care
2
2017
761
0.430
 Why?
Metabolic Diseases
1
2014
103
0.420
 Why?
Rural Population
1
2017
520
0.410
 Why?
Drug Resistance, Viral
2
2005
110
0.410
 Why?
Ventriculostomy
1
2012
21
0.380
 Why?
Chronic Pain
3
2021
253
0.380
 Why?
Ambulatory Care
2
2021
507
0.370
 Why?
Medication Errors
1
2012
96
0.370
 Why?
Mycoses
1
2012
73
0.360
 Why?
Critical Care
1
2016
552
0.360
 Why?
Central Nervous System Diseases
1
2012
68
0.360
 Why?
Prostheses and Implants
1
2012
132
0.350
 Why?
Disease Transmission, Infectious
1
2011
55
0.340
 Why?
Gram-Positive Bacterial Infections
2
2008
64
0.340
 Why?
Analgesics, Opioid
5
2021
919
0.340
 Why?
Cellulitis
2
2011
49
0.330
 Why?
Bacterial Infections
1
2012
234
0.330
 Why?
Microbiology
3
2014
24
0.330
 Why?
Physicians
5
2019
872
0.330
 Why?
Global Health
2
2018
328
0.310
 Why?
Male
39
2024
63586
0.310
 Why?
Dermatitis
1
2008
19
0.310
 Why?
Female
40
2024
68650
0.310
 Why?
Patient-Centered Care
1
2014
501
0.300
 Why?
Adult
32
2024
35505
0.300
 Why?
Medical Informatics
1
2009
99
0.300
 Why?
Education, Medical, Graduate
5
2023
439
0.300
 Why?
Gram-Negative Bacterial Infections
1
2008
45
0.300
 Why?
Middle Aged
31
2024
31087
0.290
 Why?
Information Dissemination
1
2009
204
0.280
 Why?
Africa, Eastern
2
2017
12
0.280
 Why?
AIDS Vaccines
2
2005
47
0.280
 Why?
Periodicals as Topic
1
2009
204
0.270
 Why?
Internet
2
2014
620
0.260
 Why?
Developing Countries
3
2017
282
0.260
 Why?
Pneumonia, Pneumocystis
4
2015
36
0.260
 Why?
Curriculum
5
2023
922
0.250
 Why?
Mycobacterium chelonae
1
2005
8
0.250
 Why?
Databases, Factual
2
2019
1261
0.250
 Why?
Rilpivirine
1
2024
7
0.230
 Why?
Fellowships and Scholarships
4
2023
278
0.220
 Why?
Skin
1
2008
724
0.220
 Why?
Interviews as Topic
2
2017
707
0.210
 Why?
Cost-Benefit Analysis
3
2021
566
0.210
 Why?
Meningoencephalitis
1
2003
25
0.210
 Why?
West Nile virus
1
2003
40
0.210
 Why?
Pyridones
1
2024
158
0.200
 Why?
Practice Guidelines as Topic
3
2019
1510
0.200
 Why?
Pain Management
3
2021
330
0.200
 Why?
Bacteria
1
2008
812
0.190
 Why?
Simulation Training
1
2023
82
0.190
 Why?
Anti-Infective Agents
3
2015
249
0.190
 Why?
Coronary Artery Bypass
1
2003
224
0.190
 Why?
Erythrocyte Transfusion
1
2003
182
0.180
 Why?
Mass Screening
2
2020
1186
0.180
 Why?
Colony-Stimulating Factors
1
2001
35
0.180
 Why?
Obesity
1
2014
2875
0.180
 Why?
Registries
2
2019
1902
0.180
 Why?
Contact Tracing
1
2020
24
0.180
 Why?
Sexual and Gender Minorities
1
2024
196
0.170
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
353
0.170
 Why?
Prescription Drug Misuse
1
2021
40
0.170
 Why?
Cities
4
2022
105
0.170
 Why?
Erythropoietin
1
2001
88
0.170
 Why?
Models, Theoretical
2
2021
548
0.170
 Why?
Life Expectancy
1
2020
61
0.160
 Why?
Health Equity
1
2021
87
0.160
 Why?
Cross-Sectional Studies
5
2021
5078
0.160
 Why?
Policy
1
2021
143
0.160
 Why?
Interleukin-2
1
2001
437
0.160
 Why?
Alanine
1
2020
143
0.160
 Why?
Fever of Unknown Origin
1
1999
10
0.150
 Why?
Heart Diseases
1
2022
349
0.150
 Why?
Mentors
2
2018
175
0.150
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
37
0.150
 Why?
Prevalence
5
2024
2561
0.150
 Why?
Comorbidity
2
2020
1548
0.150
 Why?
Tenofovir
1
2020
232
0.150
 Why?
Pandemics
3
2021
1500
0.150
 Why?
Microbial Sensitivity Tests
3
2016
349
0.150
 Why?
Hospitalization
4
2020
2076
0.140
 Why?
Cohort Studies
6
2019
5423
0.140
 Why?
Physician Assistants
1
2019
89
0.140
 Why?
Anti-Bacterial Agents
4
2011
1708
0.140
 Why?
Capital Financing
1
2017
7
0.140
 Why?
Patient Identification Systems
1
2017
16
0.140
 Why?
Sustained Virologic Response
1
2017
37
0.140
 Why?
Africa
1
2017
99
0.140
 Why?
Nurse Practitioners
1
2019
133
0.140
 Why?
Research Personnel
1
2018
156
0.130
 Why?
Viral Tropism
1
2016
29
0.130
 Why?
Financing, Personal
1
2016
26
0.130
 Why?
Opioid-Related Disorders
2
2021
484
0.130
 Why?
Case Management
1
2016
63
0.130
 Why?
Risk Factors
6
2019
9779
0.120
 Why?
Motivation
2
2017
547
0.120
 Why?
Hospitals
2
2021
649
0.120
 Why?
Pneumonia, Viral
1
2020
342
0.120
 Why?
Coronavirus Infections
1
2020
336
0.120
 Why?
Drug Utilization Review
1
2015
55
0.120
 Why?
Time-to-Treatment
1
2017
178
0.120
 Why?
Organizational Policy
1
2015
78
0.120
 Why?
Patient Navigation
1
2016
78
0.120
 Why?
HIV Protease Inhibitors
1
2015
68
0.120
 Why?
Esophageal Diseases
1
2015
27
0.120
 Why?
Online Systems
1
2014
22
0.120
 Why?
Candidiasis
1
2015
57
0.120
 Why?
Pregnancy Complications, Infectious
1
2019
367
0.120
 Why?
Cytosol
1
2015
219
0.110
 Why?
Healthcare Disparities
1
2020
579
0.110
 Why?
Alcoholism
1
2021
764
0.110
 Why?
Organophosphates
1
2015
122
0.110
 Why?
Ambulatory Care Facilities
1
2016
228
0.110
 Why?
Drug Interactions
1
2015
397
0.110
 Why?
Patient Readmission
1
2019
667
0.100
 Why?
DNA, Viral
2
2012
347
0.100
 Why?
Telemedicine
1
2021
792
0.100
 Why?
Aged
8
2022
22063
0.100
 Why?
Health Plan Implementation
1
2014
136
0.100
 Why?
Dihydropteroate Synthase
2
2004
3
0.100
 Why?
Pilot Projects
2
2017
1594
0.100
 Why?
Incidence
2
2021
2643
0.100
 Why?
Retrospective Studies
7
2022
14532
0.100
 Why?
Medication Reconciliation
1
2012
29
0.100
 Why?
Myocardial Infarction
2
2019
1018
0.100
 Why?
Leukocytes, Mononuclear
1
2015
546
0.100
 Why?
Longitudinal Studies
2
2019
2724
0.100
 Why?
Oligopeptides
1
2014
260
0.100
 Why?
HIV Antibodies
1
2012
57
0.100
 Why?
Socioeconomic Factors
2
2020
1211
0.090
 Why?
Primary Health Care
2
2019
1677
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Electronic Health Records
1
2019
977
0.090
 Why?
Catheter-Related Infections
1
2012
72
0.090
 Why?
Parasitic Diseases
1
2011
8
0.090
 Why?
Research
1
2014
419
0.090
 Why?
Cytomegalovirus
1
2012
154
0.090
 Why?
Health Care Costs
1
2014
366
0.090
 Why?
Pneumocystis
2
2001
11
0.090
 Why?
Mycobacterium Infections
1
2011
62
0.090
 Why?
Simian Immunodeficiency Virus
1
2011
86
0.090
 Why?
Surveys and Questionnaires
5
2023
5429
0.090
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
84
0.090
 Why?
Education, Medical, Undergraduate
1
2013
179
0.090
 Why?
Pyridines
1
2014
478
0.080
 Why?
Sulfonamides
1
2014
497
0.080
 Why?
Geography
1
2011
189
0.080
 Why?
Cytomegalovirus Infections
1
2012
190
0.080
 Why?
Deep Brain Stimulation
1
2012
125
0.080
 Why?
Rectum
1
2011
170
0.080
 Why?
Antibodies, Neutralizing
1
2012
265
0.080
 Why?
Desiccation
1
2009
20
0.080
 Why?
Colon
1
2011
257
0.080
 Why?
Emigrants and Immigrants
1
2011
122
0.080
 Why?
Education, Medical, Continuing
1
2009
121
0.070
 Why?
Drug Therapy, Combination
3
2014
1037
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
851
0.070
 Why?
Specimen Handling
1
2009
163
0.070
 Why?
Dendritic Cells
1
2011
481
0.070
 Why?
Adolescent
4
2021
20409
0.070
 Why?
Plasma
1
2009
206
0.070
 Why?
Hepacivirus
1
2009
242
0.070
 Why?
Treatment Outcome
6
2024
10232
0.070
 Why?
Risk Assessment
3
2019
3255
0.070
 Why?
B-Lymphocytes
1
2012
816
0.070
 Why?
Hepatitis C
1
2009
244
0.060
 Why?
HIV-2
1
2005
18
0.060
 Why?
CD4-Positive T-Lymphocytes
1
2011
1058
0.060
 Why?
Diagnosis, Differential
2
2007
1422
0.060
 Why?
Sex Factors
1
2011
1966
0.060
 Why?
Dapsone
2
2004
7
0.060
 Why?
Patient Education as Topic
1
2009
738
0.060
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
38
0.060
 Why?
Chronic Disease
2
2012
1722
0.060
 Why?
Pneumocystis carinii
1
2004
11
0.060
 Why?
Virulence
1
2005
255
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Vancomycin Resistance
1
2003
14
0.050
 Why?
Young Adult
2
2021
12438
0.050
 Why?
Enterococcus faecium
1
2003
14
0.050
 Why?
Delayed-Action Preparations
1
2024
172
0.050
 Why?
Wound Healing
1
2005
308
0.050
 Why?
Fatal Outcome
1
2003
300
0.050
 Why?
Liver Failure
1
2002
91
0.050
 Why?
Biopsy
1
2005
1087
0.050
 Why?
Cryptococcosis
1
2001
26
0.050
 Why?
Adipose Tissue
1
2005
594
0.050
 Why?
Transplantation, Homologous
1
2002
402
0.050
 Why?
Dental Care
1
2021
25
0.050
 Why?
Mutation
2
2004
3702
0.050
 Why?
Time Factors
3
2019
6530
0.050
 Why?
Intracranial Hypertension
1
2001
37
0.050
 Why?
Coronary Disease
2
2003
380
0.040
 Why?
Blood
2
2012
105
0.040
 Why?
Naphthoquinones
1
2001
19
0.040
 Why?
Cytochrome b Group
1
2001
18
0.040
 Why?
Quality-Adjusted Life Years
1
2021
106
0.040
 Why?
Renal Insufficiency
1
2002
149
0.040
 Why?
Patient Outcome Assessment
1
2021
126
0.040
 Why?
Trust
1
2021
116
0.040
 Why?
Meningitis
1
2001
79
0.040
 Why?
Prospective Studies
1
2012
7150
0.040
 Why?
Neutropenia
1
2001
137
0.040
 Why?
Antifungal Agents
1
2001
130
0.040
 Why?
Personal Satisfaction
1
2021
204
0.040
 Why?
Anemia
1
2001
161
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Antiviral Agents
1
2005
719
0.040
 Why?
Spinal Diseases
1
1999
47
0.040
 Why?
Asymptomatic Infections
1
2019
26
0.040
 Why?
Polyomavirus Infections
1
2019
28
0.040
 Why?
Boston
1
2019
89
0.040
 Why?
Esophageal Stenosis
1
1999
51
0.040
 Why?
Polymerase Chain Reaction
3
2011
1031
0.040
 Why?
Insurance, Health
1
2021
269
0.040
 Why?
Abscess
1
1999
73
0.040
 Why?
Health Status Disparities
1
2021
256
0.040
 Why?
Training Support
1
2018
28
0.040
 Why?
Benchmarking
1
2019
175
0.040
 Why?
Preceptorship
1
2018
63
0.040
 Why?
Substance Abuse Detection
1
2019
79
0.040
 Why?
Multicenter Studies as Topic
1
2019
287
0.040
 Why?
Recombinant Proteins
1
2001
1311
0.030
 Why?
Heart-Assist Devices
1
2003
538
0.030
 Why?
Patient Satisfaction
1
2021
636
0.030
 Why?
Dyslipidemias
1
2019
173
0.030
 Why?
Hospitals, Public
1
2017
26
0.030
 Why?
Drug Administration Schedule
1
2019
763
0.030
 Why?
Medicare
1
2022
716
0.030
 Why?
Prenatal Care
1
2019
277
0.030
 Why?
Odds Ratio
1
2019
1018
0.030
 Why?
Needs Assessment
1
2018
355
0.030
 Why?
Postpartum Period
1
2019
328
0.030
 Why?
Public Health Surveillance
1
2016
68
0.030
 Why?
Delayed Diagnosis
1
2016
79
0.030
 Why?
Multivariate Analysis
1
2019
1491
0.030
 Why?
Stents
1
1999
504
0.030
 Why?
Guideline Adherence
1
2019
526
0.030
 Why?
Motivational Interviewing
1
2016
101
0.030
 Why?
Societies, Medical
1
2018
757
0.030
 Why?
Neopterin
1
2014
12
0.030
 Why?
Darunavir
1
2014
18
0.030
 Why?
Atazanavir Sulfate
1
2014
41
0.030
 Why?
Ritonavir
1
2014
73
0.030
 Why?
Randomized Controlled Trials as Topic
1
2019
1368
0.030
 Why?
Blood Proteins
1
2014
244
0.020
 Why?
Transplantation
1
2012
31
0.020
 Why?
Inpatients
1
2016
476
0.020
 Why?
Smoking
1
2019
1501
0.020
 Why?
Rifabutin
1
2011
6
0.020
 Why?
Clarithromycin
1
2011
28
0.020
 Why?
Ofloxacin
1
2011
24
0.020
 Why?
Viremia
1
2012
132
0.020
 Why?
Quality of Life
1
2023
2694
0.020
 Why?
Receptors, Immunologic
1
2012
216
0.020
 Why?
Macaca mulatta
1
2011
150
0.020
 Why?
Integrins
1
2011
93
0.020
 Why?
RNA, Viral
1
2014
620
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1257
0.020
 Why?
Data Interpretation, Statistical
1
2012
337
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
232
0.020
 Why?
Hypertension
1
2019
1235
0.020
 Why?
Immunocompromised Host
1
2011
199
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
754
0.020
 Why?
Health Promotion
1
2015
716
0.020
 Why?
Blotting, Western
1
2011
1199
0.020
 Why?
Neoplasms
1
2002
2450
0.020
 Why?
Feces
1
2011
442
0.020
 Why?
Protein Binding
1
2014
2121
0.020
 Why?
False Negative Reactions
1
2007
52
0.020
 Why?
Flow Cytometry
1
2011
1158
0.020
 Why?
Lymphocyte Activation
1
2011
1109
0.020
 Why?
Cardiovascular Diseases
1
2019
1997
0.020
 Why?
Pregnancy
1
2019
6412
0.020
 Why?
Gene Expression Profiling
1
2011
1684
0.010
 Why?
Genotype
1
2009
1827
0.010
 Why?
T-Lymphocytes
1
2012
1935
0.010
 Why?
Chemoprevention
1
2004
91
0.010
 Why?
China
1
2004
192
0.010
 Why?
Infant
1
2016
9005
0.010
 Why?
Child, Preschool
1
2016
10499
0.010
 Why?
Atovaquone
1
2001
3
0.010
 Why?
Reproducibility of Results
1
2009
3081
0.010
 Why?
Survival
1
2001
38
0.010
 Why?
Ubiquinone
1
2001
28
0.010
 Why?
Gene Amplification
1
2001
103
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
381
0.010
 Why?
Postoperative Complications
2
2003
2475
0.010
 Why?
Biomarkers
1
2011
3968
0.010
 Why?
Sulfones
1
2000
108
0.010
 Why?
Epidural Space
1
1999
12
0.010
 Why?
Animals
2
2011
35334
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
208
0.010
 Why?
Recurrence
1
2001
1011
0.010
 Why?
Radiation Injuries
1
1999
135
0.010
 Why?
Polymorphism, Genetic
1
2001
636
0.010
 Why?
Heart Transplantation
1
2003
722
0.010
 Why?
Esophagus
1
1999
250
0.010
 Why?
Child
1
2016
20932
0.010
 Why?
Molecular Sequence Data
1
2001
2827
0.010
 Why?
Esophageal Neoplasms
1
1999
297
0.010
 Why?
Follow-Up Studies
1
2003
4891
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
628
0.010
 Why?
Case-Control Studies
1
2001
3383
0.010
 Why?
Angina Pectoris
1
1971
66
0.010
 Why?
Tomography, X-Ray Computed
1
1999
2503
0.000
 Why?
Coronary Vessels
1
1971
239
0.000
 Why?
Aorta
1
1971
407
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3392
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Extracorporeal Circulation
1
1971
13
0.000
 Why?
Methods
1
1971
63
0.000
 Why?
Saphenous Vein
1
1971
32
0.000
 Why?
Transplantation, Autologous
1
1971
213
0.000
 Why?
Emergencies
1
1971
156
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (3) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)